Both in Pharmaceuticals
BridgeBio Pharma vs TG Therapeutics
Over the past year BBIO returned +20.4% and TGTX returned +82.7%; their daily moves had a correlation of 0.26.
BBIO +20.4% TGTX +82.7%Growth of $1, one year, split-adjusted
| Metric | BBIO | TGTX |
|---|---|---|
| Price | $74.63 | $61.56 |
| Market cap | $14.54B | $9.42B |
| Today | −0.49% | +2.69% |
| 1 month | +12.8% | +14.2% |
| 6 months | +8.5% | +70.5% |
| Year to date | −2.4% | +106.5% |
| 1 year | +19.1% | +77.0% |
| Revenue growth (YoY) | +192.6% | +70.3% |
| Gross margin | 94.2% | 82.9% |
| Net margin | −23.5% | 3.2% |
| P/E (TTM) | — | 21.3× |
| Price / sales | 15.4× | 11.8× |
| Net cash | -$938.6M | -$193.1M |
| Dividend yield | — | — |
| Volatility (60d) | 32.4% | 37.1% |
| Short % of float | 12.5% | 20.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).